Jeffrey S. Smith

4.8k citations

74 papers · 3.3k indexed · 1 hit paper · h-index 30

Molecular Biology top 5%
Cellular and Molecular Neuroscience top 2%
Genetics top 5%
Oncology top 10%
Immunology top 10%

Co-authors: Sudarshan Rajagopal Robert J. Lefkowitz Andrew P. Byrnes Jie Tian Julia Laskin Alexander Laskin Zhili Xu Charles Chavkin
Topics: Receptor Mechanisms and Signaling (15 papers)Virus-based gene therapy research (11 papers)RNA Interference and Gene Delivery (7 papers)
Cited by: Cellular and Molecular Neuroscience Behavioral Neuroscience Molecular Biology
Journals: Nature Science Proceedings of the National Academy of Sciences
Partner nations: United States Japan Russia

In The Last Decade

Jeffrey S. Smith

71 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biased signalling: from simple switches to allosteric microprocessors

2018 514 citations Jeffrey S. Smith, Robert J. Lefkowitz et al. Nature Reviews Drug Discovery profile →

Peers

Countries citing papers authored by Jeffrey S. Smith

Since Specialization

Citations

This map shows the geographic impact of Jeffrey S. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey S. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey S. Smith more than expected).

Fields of papers citing papers by Jeffrey S. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey S. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey S. Smith. The network helps show where Jeffrey S. Smith may publish in the future.

Co-authorship network of co-authors of Jeffrey S. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey S. Smith. A scholar is included among the top collaborators of Jeffrey S. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey S. Smith. Jeffrey S. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inter-Rater and Intra-Rater Reliability of the Cutaneous Lupus Activity-Investigator Global Assessment-Revised Instrument 2025 ·Journal of Investigative Dermatology ·Joseph F. Merola,(unknown),(unknown),(unknown),Jeffrey S. Smith,Benjamin F. Chong,Alice B. Gottlieb,Victoria P. Werth,Scott A. Elman,Lourdes M. Pérez-Chada	0
2	Heterogeneity of tethered agonist signaling in adhesion G protein-coupled receptors 2024 ·Cell chemical biology ·(unknown),(unknown),Jeffrey S. Smith,Meredith A. Skiba,(unknown),(unknown),Andrew C. Kruse,Stephen C. Blacklow	10
3	The M3 Muscarinic Acetylcholine Receptor Can Signal through Multiple G Protein Families 2024 ·Molecular Pharmacology ·Jeffrey S. Smith,(unknown),Meredith A. Skiba,(unknown),(unknown),Andrew C. Kruse	2
4	From pre-test and post-test probabilities to medical decision making 2024 ·BMC Medical Informatics and Decision Making ·(unknown),(unknown),Claire Smith,Jeffrey S. Smith,Mark Sendak,Christopher R. Polage,Justin D. Silverman	0
5	Anifrolumab for the treatment of refractory chilblain lupus erythematosus 2023 ·JAAD Case Reports ·(unknown),(unknown),Jeffrey S. Smith,Joseph F. Merola	1
6	Evaluation of luciferase and prefusion-stabilized F protein from respiratory syncytial virus mRNA/LNPs in pre-clinical models using jet delivery compared to needle and syringe 2023 ·Vaccine X ·Brian K. Meyer,Debbie Nahas,(unknown),Andrew Danziger,Jeffrey S. Smith,Manish Patel,Shu-An Lin,(unknown),Kara S. Cox,(unknown),John A. Howe,Andrew Bett	3
7	Diagnosis of mycosis fungoides or Sézary syndrome after dupilumab use: A systematic review 2022 ·Journal of the American Academy of Dermatology ·Abdulhadi Jfri,Jeffrey S. Smith,Cecilia Larocca	13
8	Noncanonical scaffolding of G _αi and β-arrestin by G protein–coupled receptors 2021 ·Science ·Jeffrey S. Smith,Thomas F. Pack,Asuka Inoue,(unknown),(unknown),Issac Choi,Dylan Scott Eiger,Anmol Warman,Xinyu Xiong,Zhiyuan Ma,Gayathri Viswanathan,(unknown),Lauren K. Rochelle,Dean P. Staus,Joshua C. Snyder,Alem W. Kahsai,Marc G. Caron,Sudarshan Rajagopal	73
9	Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants 2019 ·Vaccine ·Sita Awasthi,Lauren M. Hook,Gokul Swaminathan,Tina M. Cairns,Benjamin D. Brooks,Jeffrey S. Smith,(unknown),Marian E. Gindy,Andrew J. Bett,Amy S. Espeseth,Gary H. Cohen,Harvey M. Friedman	14
10	Manifold roles of β-arrestins in GPCR signaling elucidated with siRNA and CRISPR/Cas9 2018 ·Science Signaling ·Louis M. Luttrell,Jialu Wang,Bianca Plouffe,Jeffrey S. Smith,Lama Yamani,Suneet Kaur,Pierre‐Yves Jean‐Charles,Christophe Gauthier,Mi‐Hye Lee,Biswaranjan Pani,Ji‐Hee Kim,Seungkirl Ahn,Sudarshan Rajagopal,Éric Reiter,Michel Bouvier,Sudha K. Shenoy,Stéphane A. Laporte,Howard A. Rockman,Robert J. Lefkowitz	153
11	Chemokine Signaling in Allergic Contact Dermatitis: Toward Targeted Therapies 2018 ·Dermatitis ·Jeffrey S. Smith,Sudarshan Rajagopal,Amber Reck Atwater	16
12	Biased signalling: from simple switches to allosteric microprocessorsbreakdown → 2018 ·Nature Reviews Drug Discovery ·Jeffrey S. Smith,Robert J. Lefkowitz,Sudarshan Rajagopal	514
13	Mechanism of Macromolecular Structure Evolution in Self-Assembled Lipid Nanoparticles for siRNA Delivery 2014 ·Langmuir ·Marian E. Gindy,(unknown),Varun Kumar,Robert K. Prud’homme,(unknown),Robert Haas,Jeffrey S. Smith,D. I. Boardman	53
14	PKA catalytic subunit compartmentation regulates contractile and hypertrophic responses to β-adrenergic signaling 2013 ·Journal of Molecular and Cellular Cardiology ·Jason H. Yang,Renata Polanowska‐Grabowska,Jeffrey S. Smith,C. Wyatt Shields,Jeffrey J. Saucerman	43
15	Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement 2013 ·Nature Medicine ·Zhili Xu,(unknown),Jie Tian,Jeffrey S. Smith,Gina M. Conenello,Takashi Morita,Andrew P. Byrnes	121
16	Stress Produces Aversion and Potentiates Cocaine Reward by Releasing Endogenous Dynorphins in the Ventral Striatum to Locally Stimulate Serotonin Reuptake 2012 ·Journal of Neuroscience ·Abigail G. Schindler,Daniel I. Messinger,Jeffrey S. Smith,Haripriya Shankar,Richard M. Gustin,Selena S. Schattauer,Julia C. Lemos,Nicholas W. Chavkin,Catherine E. Hagan,John F. Neumaier,Charles Chavkin	93
17	The Role of Endosomal Escape and Mitogen-Activated Protein Kinases in Adenoviral Activation of the Innate Immune Response 2011 ·PLoS ONE ·Jeffrey S. Smith,Zhili Xu,Jie Tian,Donna Palmer,Philip Ng,Andrew P. Byrnes	15
18	Rapid Kupffer cell death after intravenous injection of adenovirus vectors 2005 ·Molecular Therapy ·Elanchezhiyan Manickan,Jeffrey S. Smith,Jie Tian,Thomas L. Eggerman,Jay N. Lozier,Jacqueline Müller,Andrew P. Byrnes	107
19	Severe pulmonary pathology after intravenous administration of vectors in cirrhotic rats 2004 ·Molecular Therapy ·Jeffrey S. Smith,Jie Tian,Jay N. Lozier,Andrew P. Byrnes	37
20	Activation of MAPK by TRH Requires Clathrin-Dependent Endocytosis and PKC but Not Receptor Interaction with β-Arrestin or Receptor Endocytosis 2001 ·Molecular Endocrinology ·Jeffrey S. Smith,Run Yu,Patricia M. Hinkle	26

About Jeffrey S. Smith

Jeffrey S. Smith is a scholar working on Chemical Health and Safety, Dermatology and Cellular and Molecular Neuroscience, having authored 74 papers that have together received 3.3k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (15 papers), Virus-based gene therapy research (11 papers) and RNA Interference and Gene Delivery (7 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (909 citations), Behavioral Neuroscience (164 citations) and Molecular Biology (1.8k citations). Jeffrey S. Smith has collaborated with scholars based in United States, Japan and Russia. Frequent co-authors include Sudarshan Rajagopal, Robert J. Lefkowitz, Andrew P. Byrnes, Jie Tian, Julia Laskin, Alexander Laskin, Zhili Xu, Charles Chavkin, Kalliat T. Valsaraj and Julia C. Lemos. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact